Accepted for/Published in: JMIR Dermatology
Date Submitted: Aug 2, 2023
Open Peer Review Period: Jul 27, 2023 - Sep 21, 2023
Date Accepted: Jan 28, 2024
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Social Media Use in Dermatology in Turkey: Challenges and Tips for Patient Health
ABSTRACT
Social media (SM) has established its place in our daily lives with the COVID-19 pandemic and is the leading source of information for dermatologic literacy on various topics, from skin diseases to everyday skincare or cosmetic purposes in the present digital era. Accumulated evidence indicates that accurate medical content constitutes only a tiny fraction of the exponentially growing dermatological information on digital platforms, and there is an unmet patient need to access evidence-based information on SM. However, no publication analyzes and assesses the key elements in raising dermatologic literacy and awareness in digital communication for patients in Turkey. The present study is the first in the literature to define real-world applications in this particular field in one of Turkey's most widely used information sources. This expert panel aimed to discuss the role of dermatologists in combating misinformation and possible solutions to increase the knowledge and awareness of patients as well as to address paradigms to facilitate dermatologic outreach on SM platforms in Turkey.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.